Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection

This study has been completed.
Information provided by (Responsible Party):
Marco Braga, Università Vita-Salute San Raffaele
ClinicalTrials.gov Identifier:
First received: January 14, 2011
Last updated: December 21, 2012
Last verified: December 2012
No comparative trial investigating the effect of preoperative chemotherapy for locally advanced pancreatic cancer on short-term postoperative outcome has been published so far. The aim of the present study is to assess the potential impact of preoperative chemotherapy on short-term postoperative outcome after pancreatic resection in a case-matched series of cancer patients.

Condition Intervention
Locally Advanced Pancreatic Adenocarcinoma
Procedure: Pancreatic resection after preoperative chemotherapy
Procedure: Pancreatic resection

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Università Vita-Salute San Raffaele:

Primary Outcome Measures:
  • Postoperative morbidity rate [ Time Frame: Postoperative. From 0 to 30 days after discharge ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Postoperative mortality [ Time Frame: Postoperative. From 0 to 30 days after discharge ] [ Designated as safety issue: No ]
  • Length of hospital stay (LOS) [ Time Frame: Postoperative. From 0 to 30 days after discharge ] [ Designated as safety issue: No ]

Enrollment: 150
Study Start Date: January 2003
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Preoperative chemotherapy (PCHT)
Patients who underwent pancreatic resection after PCHT.
Procedure: Pancreatic resection after preoperative chemotherapy
Pancreatic resection after preoperative chemotherapy
Active Comparator: Control
Patient who underwent pancreatic resection without preoperative therapy
Procedure: Pancreatic resection
Pancreatic resection

Detailed Description:
Between 2003 and 2011, patients with locally advanced (stage III) pancreatic cancer who were treated with preoperative chemotherapy (PCHT) underwent surgical resection. Each patient was matched with the closest two patients with pancreatic cancer ( control group ) selected from our prospective electronic database who met the following match criteria: age (+/- 3 years), gender, ASA score, type of resection, pancreatic duct diameter (+/- 1 mm), and tumour size (+/- 5 mm).

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of pancreatic cancer
  • Preoperative chemotherapy
  • Pancreatic resection

Exclusion Criteria:

  • Metastatic disease
  • ASA score 4
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01278368

San Raffaele Hospital
Milan, Italy, 20132
Sponsors and Collaborators
Università Vita-Salute San Raffaele
Principal Investigator: Marco Braga, MD Università Vita-Salute San Raffaele
  More Information

No publications provided

Responsible Party: Marco Braga, Associate Professor of Surgery, Università Vita-Salute San Raffaele
ClinicalTrials.gov Identifier: NCT01278368     History of Changes
Other Study ID Numbers: NEOADJUVANT_MATCH 
Study First Received: January 14, 2011
Last Updated: December 21, 2012
Health Authority: Italy: Ministry of Health

Keywords provided by Università Vita-Salute San Raffaele:
pancreatic cancer, neoadjuvant chemotherapy

Additional relevant MeSH terms:
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on February 04, 2016